🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to monitor safety outcomes for patients being ...
Status
Unknown
Location
Southeast Retina
Start Date
2013-03
Trial ID
NCT01790893
Treatments Being Tested
This is an observational study to collect data from Japanese babies with re...
Status
Active Not Recruiting
Location
Many locations
Start Date
2023-03-27
Trial ID
NCT05705258
Treatments Being Tested
The Endurance Trial is a phase IV open label clinical study to assess the n...
Status
Completed
Location
Multiple Locations
Start Date
2014-11
Trial ID
NCT02297204
Treatments Being Tested
The treatment landscape for neovascular AMD has evolved with various anti-V...
Status
Completed
Location
Kim's Eye Hospital
Start Date
2024-10-21
Trial ID
NCT06683950
Treatments Being Tested
This study aims to evaluate the optimal use, efficacy, and safety of a Trea...
Status
Completed
Location
Multiple Locations
Start Date
2015-11-19
Trial ID
NCT02581891
The purpose of this study is to compare brolucizumab (RTH258) ophthalmic so...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2014-12-08
Trial ID
NCT02307682
Treatments Being Tested
The main goal is to study way that aflibercept injection behaves in the eye...
Status
Completed
Location
University of Nebraska Medical Center, Truhlsen Eye Institute
Start Date
2014-09-05
Trial ID
NCT02204683
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of X-82 in...
Status
Terminated
Location
Multiple Locations
Start Date
2015-03-16
Trial ID
NCT02348359
The French CODEX study is designed as a national database to describe, in r...
Status
Completed
Location
Multiple Locations
Start Date
2016-09-30
Trial ID
NCT02811692
Treatments Being Tested
Regeneron Pharmaceuticals developed a single-dose pre-filled syringe (PFS) ...
Status
Completed
Location
Retina Consultants of Texas
Start Date
2024-04-15
Trial ID
NCT05989126
Treatments Being Tested